Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 460

1.

The risk of arterial thromboembolic events after cancer diagnosis.

Navi BB, Howard G, Howard VJ, Zhao H, Judd SE, Elkind MSV, Iadecola C, DeAngelis LM, Kamel H, Okin PM, Gilchrist S, Soliman EZ, Cushman M, Safford M, Muntner P.

Res Pract Thromb Haemost. 2019 Jun 9;3(4):639-651. doi: 10.1002/rth2.12223. eCollection 2019 Oct.

2.

Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study.

Decker JJ, Norby FL, Rooney MR, Soliman EZ, Lutsey PL, Pankow JS, Alonso A, Chen LY.

Stroke. 2019 Oct 18:STROKEAHA119025376. doi: 10.1161/STROKEAHA.119.025376. [Epub ahead of print]

PMID:
31623543
3.

Prevalence and Characteristics of Subclinical Atrial Fibrillation in a Community-Dwelling Elderly Population: The ARIC Study.

Rooney MR, Soliman EZ, Lutsey PL, Norby FL, Loehr LR, Mosley TH, Zhang M, Gottesman RF, Coresh J, Folsom AR, Alonso A, Chen LY.

Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007390. doi: 10.1161/CIRCEP.119.007390. Epub 2019 Oct 14.

PMID:
31607148
4.

Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.

Bansal N, Zelnick L, Shlipak MG, Anderson A, Christenson R, Deo R, Defilippi C, Feldman H, Lash J, He J, Kusek J, Ky B, Seliger S, Soliman EZ, Go AS; CRIC Study Investigators.

Clin Chem. 2019 Oct 2. pii: clinchem.2019.305797. doi: 10.1373/clinchem.2019.305797. [Epub ahead of print]

PMID:
31578216
5.

Resting Heart Rate, Short-Term Heart Rate Variability and Incident Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis (MESA)).

Habibi M, Chahal H, Greenland P, Guallar E, Lima JAC, Soliman EZ, Alonso A, Heckbert SR, Nazarian S.

Am J Cardiol. 2019 Sep 6. pii: S0002-9149(19)30991-9. doi: 10.1016/j.amjcard.2019.08.025. [Epub ahead of print]

PMID:
31575421
6.

Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.

Almuwaqqat Z, O'Neal WT, Norby FL, Lutsey PL, Selvin E, Soliman EZ, Chen LY, Alonso A.

J Am Heart Assoc. 2019 Oct;8(19):e013294. doi: 10.1161/JAHA.119.013294. Epub 2019 Sep 28.

7.

Associations between QT interval subcomponents, HIV serostatus, and inflammation.

Wu KC, Bhondoekhan F, Haberlen SA, Ashikaga H, Brown TT, Budoff MJ, D'Souza G, Magnani JW, Kingsley LA, Palella FJ, Margolick JB, Martínez-Maza O, Altekruse SF, Soliman EZ, Post WS.

Ann Noninvasive Electrocardiol. 2019 Sep 19:e12705. doi: 10.1111/anec.12705. [Epub ahead of print]

PMID:
31538387
8.

Atrial cardiopathy and stroke mortality in the general population.

Ahmad MI, Singleton MJ, Bhave PD, Kamel H, Soliman EZ.

Int J Stroke. 2019 Sep 17:1747493019876543. doi: 10.1177/1747493019876543. [Epub ahead of print]

PMID:
31530133
9.

Short-term repeatability of electrocardiographic criteria of left ventricular hypertrophy.

Meyer ML, Soliman EZ, Drager D, Heiss G.

Ann Noninvasive Electrocardiol. 2019 Sep 9:e12688. doi: 10.1111/anec.12688. [Epub ahead of print]

PMID:
31498512
10.

Relation of total bilirubin and QT interval prolongation (from the Third National Health and Nutrition Examination Survey).

Majeed CN, Ahmad MI, Ahsan I, Anees MA, Maheshwari SK, Soliman EZ.

Ann Noninvasive Electrocardiol. 2019 Sep 9:e12696. doi: 10.1111/anec.12696. [Epub ahead of print]

PMID:
31498504
11.

Prognostic implications of QRS dispersion for major adverse cardiovascular events in asymptomatic women and men: the Multi-Ethnic Study of Atherosclerosis.

Jain R, Gautam S, Wu C, Shen C, Jain A, Giesdal O, Chahal H, Lin H, Bluemke DA, Soliman EZ, Nazarian S, Lima JAC.

J Interv Card Electrophysiol. 2019 Oct;56(1):45-53. doi: 10.1007/s10840-019-00614-y. Epub 2019 Sep 3.

PMID:
31482330
12.

Association of novel measures of sleep disturbances with blood pressure: the Multi-Ethnic Study of Atherosclerosis.

Kim JS, Azarbarzin A, Wang R, Djonlagic IE, Punjabi NM, Zee PC, Koo BB, Soliman EZ, Younes M, Redline S.

Thorax. 2019 Aug 22. pii: thoraxjnl-2019-213533. doi: 10.1136/thoraxjnl-2019-213533. [Epub ahead of print]

PMID:
31439722
13.

Electrocardiographic Diagnosis of Atrial Arrhythmias.

Soliman EZ, Bhave PD, Chen LY.

JAMA. 2019 Aug 20;322(7):688-689. doi: 10.1001/jama.2019.10925. No abstract available.

PMID:
31429875
14.

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.

Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, Shafi T, Go AS, Bansal N; CRIC Study Investigators.

J Am Heart Assoc. 2019 Aug 6;8(15):e012200. doi: 10.1161/JAHA.119.012200. Epub 2019 Aug 5.

15.

The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to Whites: The Atherosclerosis Risk in Communities (ARIC) study.

Loehr LR, Soliman EZ, Poon AK, Couper D, Chen LY, Mosley TH, Wagenknecht LE, Whitsel EA, Alonso A, Wruck L, Heiss G.

Am Heart J. 2019 Jul 3;216:1-8. doi: 10.1016/j.ahj.2019.06.017. [Epub ahead of print]

16.

Neighborhood environments and risk of incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Garg PK, Jorgensen N, Diez-Roux AV, O'Neal W, Mujahid M, Moore K, Soliman EZ, Heckbert SR.

Eur J Prev Cardiol. 2019 Jul 26:2047487319866020. doi: 10.1177/2047487319866020. [Epub ahead of print] No abstract available.

PMID:
31349772
17.

Interrelation Between Electrocardiographic Left Atrial Abnormality, Left Ventricular Hypertrophy, and Mortality in Participants With Hypertension.

Ahmad MI, Mujtaba M, Anees MA, Li Y, Soliman EZ.

Am J Cardiol. 2019 Sep 15;124(6):886-891. doi: 10.1016/j.amjcard.2019.06.003. Epub 2019 Jun 25.

PMID:
31324356
18.

Serum Cotinine and Silent Myocardial Infarction in Individuals Free from Cardiovascular Disease.

Brunetti R, Hicklin H, Rackley J, Ahmad MI, Li Y, Soliman EZ.

Am J Cardiol. 2019 Sep 1;124(5):666-670. doi: 10.1016/j.amjcard.2019.05.064. Epub 2019 Jun 6.

PMID:
31272704
19.

Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.

Upadhya B, Rocco MV, Pajewski NM, Morgan T, Blackshear J, Hundley WG, Oparil S, Soliman EZ, Cohen DL, Hamilton CA, Cho ME, Kostis WJ, Papademetriou V, Rodriguez CJ, Raj DS, Townsend R, Vasu S, Zamanian S, Kitzman DW; SPRINT Research Group * .

Hypertension. 2019 Jul 1:HYPERTENSIONAHA11913073. doi: 10.1161/HYPERTENSIONAHA.119.13073. [Epub ahead of print]

PMID:
31256724
20.

GWAS of QRS duration identifies new loci specific to Hispanic/Latino populations.

Swenson BR, Louie T, Lin HJ, Méndez-Giráldez R, Below JE, Laurie CC, Kerr KF, Highland H, Thornton TA, Ryckman KK, Kooperberg C, Soliman EZ, Seyerle AA, Guo X, Taylor KD, Yao J, Heckbert SR, Darbar D, Petty LE, McKnight B, Cheng S, Bello NA, Whitsel EA, Hanis CL, Nalls MA, Evans DS, Rotter JI, Sofer T, Avery CL, Sotoodehnia N.

PLoS One. 2019 Jun 28;14(6):e0217796. doi: 10.1371/journal.pone.0217796. eCollection 2019.

21.

Baseline ST elevation and myocardial scar: Results from the multi-ethnic study of atherosclerosis.

Markman TM, Bluemke D, Soliman EZ, Wu C, Kawel-Boehm N, Lima JAC, Nazarian S.

J Electrocardiol. 2019 Sep - Oct;56:29-33. doi: 10.1016/j.jelectrocard.2019.06.013. Epub 2019 Jun 18.

PMID:
31247443
22.

Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals.

Noordam R, Young WJ, Salman R, Kanters JK, van den Berg ME, van Heemst D, Lin HJ, Barreto SM, Biggs ML, Biino G, Catamo E, Concas MP, Ding J, Evans DS, Foco L, Grarup N, Lyytikäinen LP, Mangino M, Mei H, van der Most PJ, Müller-Nurasyid M, Nelson CP, Qian Y, Repetto L, Said MA, Shah N, Schramm K, Vidigal PG, Weiss S, Yao J, Zilhao NR, Brody JA, Braund PS, Brumat M, Campana E, Christofidou P, Caulfield MJ, De Grandi A, Dominiczak AF, Doney ASF, Eiriksdottir G, Ellervik C, Giatti L, Gögele M, Graff C, Guo X, van der Harst P, Joshi PK, Kähönen M, Kestenbaum B, Lima-Costa MF, Linneberg A, Maan AC, Meitinger T, Padmanabhan S, Pattaro C, Peters A, Petersmann A, Sever P, Sinner MF, Shen X, Stanton A, Strauch K, Soliman EZ, Tarasov KV, Taylor KD, Thio CHL, Uitterlinden AG, Vaccargiu S, Waldenberger M, Robino A, Correa A, Cucca F, Cummings SR, Dörr M, Girotto G, Gudnason V, Hansen T, Heckbert SR, Juhl CR, Kääb S, Lehtimäki T, Liu Y, Lotufo PA, Palmer CNA, Pirastu M, Pramstaller PP, Ribeiro ALP, Rotter JI, Samani NJ, Snieder H, Spector TD, Stricker BH, Verweij N, Wilson JF, Wilson JG, Jukema JW, Tinker A, Newton-Cheh CH, Sotoodehnia N, Mook-Kanamori DO, Munroe PB, Warren HR.

J Am Coll Cardiol. 2019 Jun 25;73(24):3118-3131. doi: 10.1016/j.jacc.2019.03.519.

PMID:
31221261
23.

Electrocardiographic definition of silent myocardial infarction in population studies: A call to standardize the standards.

Soliman EZ.

J Electrocardiol. 2019 Jul - Aug;55:128-132. doi: 10.1016/j.jelectrocard.2019.05.008. Epub 2019 May 18.

PMID:
31170595
24.

Cannabis Use and Markers of Systemic Inflammation: The Coronary Artery Risk Development in Young Adults Study.

Alshaarawy O, Sidney S, Auer R, Green D, Soliman EZ, Goff DC Jr, Anthony JC.

Am J Med. 2019 May 29. pii: S0002-9343(19)30442-5. doi: 10.1016/j.amjmed.2019.04.045. [Epub ahead of print]

PMID:
31150645
25.

Association of Antidepressant Medication Type With the Incidence of Cardiovascular Disease in the ARIC Study.

Almuwaqqat Z, Jokhadar M, Norby FL, Lutsey PL, O'Neal WT, Seyerle A, Soliman EZ, Chen LY, Bremner JD, Vaccarino V, Shah AJ, Alonso A.

J Am Heart Assoc. 2019 Jun 4;8(11):e012503. doi: 10.1161/JAHA.119.012503. Epub 2019 May 29.

26.

Plasma total testosterone and risk of incident atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Berger D, Folsom AR, Schreiner PJ, Chen LY, Michos ED, O'Neal WT, Soliman EZ, Alonso A.

Maturitas. 2019 Jul;125:5-10. doi: 10.1016/j.maturitas.2019.03.015. Epub 2019 Mar 31.

PMID:
31133217
27.

P Wave Indices-Advancing Our Understanding of Atrial Fibrillation-Related Cardiovascular Outcomes.

Chen LY, Soliman EZ.

Front Cardiovasc Med. 2019 May 3;6:53. doi: 10.3389/fcvm.2019.00053. eCollection 2019. Review.

28.

Is Left Ventricular Hypertrophy a Valid Therapeutic Target?

Brooks JE, Soliman EZ, Upadhya B.

Curr Hypertens Rep. 2019 May 20;21(6):47. doi: 10.1007/s11906-019-0952-9. Review.

PMID:
31111289
29.

Relation of Marital Status and QT Interval Prolongation (from the Third National Health and Nutrition Examination Survey).

Ahmad MI, Majeed CN, Chaudhary D, Dutta A, Jogu HR, Soliman EZ.

Am J Cardiol. 2019 Jul 15;124(2):211-215. doi: 10.1016/j.amjcard.2019.04.020. Epub 2019 Apr 23.

PMID:
31084996
30.

Multiple SCN5A variant enhancers modulate its cardiac gene expression and the QT interval.

Kapoor A, Lee D, Zhu L, Soliman EZ, Grove ML, Boerwinkle E, Arking DE, Chakravarti A.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):10636-10645. doi: 10.1073/pnas.1808734116. Epub 2019 May 8.

PMID:
31068470
31.

Prevalence of atrial fibrillation and association with clinical, sociocultural, and ancestral correlates among Hispanic/Latinos: The Hispanic Community Health Study/Study of Latinos.

Linares JD, Jackson LR 2nd, Dawood FZ, Swett K, Benjamin EJ, Schneiderman N, Soliman EZ, Cai J, Alonso A, Wassertheil-Smoller S, Talavera GA, Daubert JP, Daviglus ML, Rodriguez CJ.

Heart Rhythm. 2019 May;16(5):686-693. doi: 10.1016/j.hrthm.2018.11.033.

PMID:
31036248
32.

Association of sickle cell trait with atrial fibrillation: The REGARDS cohort.

Douce DR, Soliman EZ, Naik R, Hyacinth HI, Cushman M, Winkler CA, Howard G, Lange EM, Lange LA, Irvin MR, Zakai NA.

J Electrocardiol. 2019 Jul - Aug;55:1-5. doi: 10.1016/j.jelectrocard.2019.04.010. Epub 2019 Apr 16.

PMID:
31028976
33.

Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study).

Alonso A, Yu B, Sun YV, Chen LY, Loehr LR, O'Neal WT, Soliman EZ, Boerwinkle E.

Am J Cardiol. 2019 Jun 15;123(12):1955-1961. doi: 10.1016/j.amjcard.2019.03.017. Epub 2019 Mar 18.

PMID:
30979411
34.

Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities.

Berman JP, Norby FL, Mosley T, Soliman EZ, Gottesman RF, Lutsey PL, Alonso A, Chen LY.

Stroke. 2019 Apr;50(4):783-788. doi: 10.1161/STROKEAHA.118.024143.

PMID:
30908155
35.

Prognostic significance of electrocardiographic right ventricular hypertrophy in the general population.

Kowal J, Ahmad MI, Li Y, Soliman EZ.

J Electrocardiol. 2019 May - Jun;54:49-53. doi: 10.1016/j.jelectrocard.2019.03.008. Epub 2019 Mar 13.

PMID:
30901607
36.

Association of Atrial Fibrillation With White Matter Disease.

Shao IY, Power MC, Mosley T, Jack C Jr, Gottesman RF, Chen LY, Norby FL, Soliman EZ, Alonso A.

Stroke. 2019 Apr;50(4):989-991. doi: 10.1161/STROKEAHA.118.023386.

PMID:
30879437
37.

Interrelationships Between American Heart Association's Life's Simple 7, ECG Silent Myocardial Infarction, and Cardiovascular Mortality.

Ahmad MI, Chevli PA, Barot H, Soliman EZ.

J Am Heart Assoc. 2019 Mar 19;8(6):e011648. doi: 10.1161/JAHA.118.011648.

38.

Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA.

Sparapani R, Dabbouseh NM, Gutterman D, Zhang J, Chen H, Bluemke DA, Lima JAC, Burke GL, Soliman EZ.

J Am Heart Assoc. 2019 Mar 5;8(5):e009959. doi: 10.1161/JAHA.118.009959. Erratum in: J Am Heart Assoc. 2019 May 7;8(9):e002294.

39.

Relation of Minor Electrocardiographic Abnormalities to Cardiovascular Mortality.

Hari KJ, Singleton MJ, Ahmad MI, Soliman EZ.

Am J Cardiol. 2019 May 1;123(9):1443-1447. doi: 10.1016/j.amjcard.2019.01.050. Epub 2019 Feb 10.

PMID:
30792000
40.

Sex Differences in Risk Factors for Incident Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke [REGARDS] Study).

Bose A, O'Neal WT, Wu C, McClure LA, Judd SE, Howard VJ, Howard G, Soliman EZ.

Am J Cardiol. 2019 May 1;123(9):1453-1457. doi: 10.1016/j.amjcard.2019.01.056. Epub 2019 Feb 10.

PMID:
30771859
41.

Risk of Atrial Fibrillation in Black Versus White Medicare Beneficiaries With Implanted Cardiac Devices.

Chen ML, Parikh NS, Merkler AE, Kleindorfer DO, Bhave PD, Levitan EB, Soliman EZ, Kamel H.

J Am Heart Assoc. 2019 Feb 19;8(4):e010661. doi: 10.1161/JAHA.118.010661.

42.

Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women.

Boursiquot BC, Larson JC, Shalash OA, Vitolins MZ, Soliman EZ, Perez MV.

Am Heart J. 2019 Mar;209:68-78. doi: 10.1016/j.ahj.2018.12.006. Epub 2018 Dec 13.

PMID:
30685677
43.

Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits.

van Setten J, Verweij N, Mbarek H, Niemeijer MN, Trompet S, Arking DE, Brody JA, Gandin I, Grarup N, Hall LM, Hemerich D, Lyytikäinen LP, Mei H, Müller-Nurasyid M, Prins BP, Robino A, Smith AV, Warren HR, Asselbergs FW, Boomsma DI, Caulfield MJ, Eijgelsheim M, Ford I, Hansen T, Harris TB, Heckbert SR, Hottenga JJ, Iorio A, Kors JA, Linneberg A, MacFarlane PW, Meitinger T, Nelson CP, Raitakari OT, Silva Aldana CT, Sinagra G, Sinner M, Soliman EZ, Stoll M, Uitterlinden A, van Duijn CM, Waldenberger M, Alonso A, Gasparini P, Gudnason V, Jamshidi Y, Kääb S, Kanters JK, Lehtimäki T, Munroe PB, Peters A, Samani NJ, Sotoodehnia N, Ulivi S, Wilson JG, de Geus EJC, Jukema JW, Stricker B, van der Harst P, de Bakker PIW, Isaacs A.

Eur J Hum Genet. 2019 Jun;27(6):952-962. doi: 10.1038/s41431-018-0295-z. Epub 2019 Jan 24.

44.

Association of vitamin D deficiency with electrocardiographic markers of left atrial abnormalities.

Anees MA, Ahmad MI, Chevli PA, Li Y, Soliman EZ.

Ann Noninvasive Electrocardiol. 2019 May;24(3):e12626. doi: 10.1111/anec.12626. Epub 2019 Jan 19.

PMID:
30659705
45.

Association of obesity phenotypes with electrocardiographic subclinical myocardial injury in the general population.

Vasim I, Ahmad MI, Mongraw-Chaffin M, Soliman EZ.

Clin Cardiol. 2019 Mar;42(3):373-378. doi: 10.1002/clc.23155. Epub 2019 Feb 6.

46.

Interrelations Between Serum Uric Acid, Silent Myocardial Infarction, and Mortality in the General Population.

Ahmad MI, Dutta A, Anees MA, Soliman EZ.

Am J Cardiol. 2019 Mar 15;123(6):882-888. doi: 10.1016/j.amjcard.2018.12.016. Epub 2018 Dec 19.

PMID:
30617009
47.

Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score.

Maheshwari A, Norby FL, Roetker NS, Soliman EZ, Koene RJ, Rooney MR, O'Neal WT, Shah AM, Claggett BL, Solomon SD, Alonso A, Gottesman RF, Heckbert SR, Chen LY.

Circulation. 2019 Jan 8;139(2):180-191. doi: 10.1161/CIRCULATIONAHA.118.035411.

PMID:
30586710
48.

Negative Affect and Risk of Atrial Fibrillation: MESA.

Garg PK, O'Neal WT, Diez-Roux AV, Alonso A, Soliman EZ, Heckbert S.

J Am Heart Assoc. 2019 Jan 8;8(1):e010603. doi: 10.1161/JAHA.118.010603.

49.

Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors.

Howard VJ, Madsen TE, Kleindorfer DO, Judd SE, Rhodes JD, Soliman EZ, Kissela BM, Safford MM, Moy CS, McClure LA, Howard G, Cushman M.

JAMA Neurol. 2019 Feb 1;76(2):179-186. doi: 10.1001/jamaneurol.2018.3862.

PMID:
30535250
50.

Relation of the CHA2DS2-VASc Score to Risk of Thrombotic and Embolic Stroke in Community-Dwelling Individuals Without Atrial Fibrillation (From The Atherosclerosis Risk in Communities [ARIC] Study).

Koene RJ, Alraies MC, Norby FL, Soliman EZ, Maheshwari A, Lip GYH, Alonso A, Chen LY.

Am J Cardiol. 2019 Feb 1;123(3):402-408. doi: 10.1016/j.amjcard.2018.10.037. Epub 2018 Nov 6.

PMID:
30527796

Supplemental Content

Loading ...
Support Center